Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines
- PMID: 20431339
- PMCID: PMC2936654
- DOI: 10.4161/hv.6.2.11333
Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines
Similar articles
-
Additional seasonal influenza virus vaccinations for the 2009 H1N1 pandemic.Clin Vaccine Immunol. 2010 May;17(5):887-8. doi: 10.1128/CVI.00003-10. Epub 2010 Mar 10. Clin Vaccine Immunol. 2010. PMID: 20219879 Free PMC article. No abstract available.
-
Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.PLoS One. 2014 Aug 27;9(8):e105651. doi: 10.1371/journal.pone.0105651. eCollection 2014. PLoS One. 2014. PMID: 25162670 Free PMC article.
-
Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.J Virol. 2018 May 14;92(11):e00114-18. doi: 10.1128/JVI.00114-18. Print 2018 Jun 1. J Virol. 2018. PMID: 29563292 Free PMC article.
-
Return of inactivated whole-virus vaccine for superior efficacy.Immunol Cell Biol. 2012 Jul;90(6):571-8. doi: 10.1038/icb.2011.70. Epub 2011 Aug 16. Immunol Cell Biol. 2012. PMID: 21844883 Review.
-
Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.Am J Epidemiol. 2018 Dec 1;187(12):2603-2614. doi: 10.1093/aje/kwy145. Am J Epidemiol. 2018. PMID: 30084906 Free PMC article. Review.
Cited by
-
Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.Hum Vaccin Immunother. 2014;10(2):256-62. doi: 10.4161/hv.28135. Epub 2014 Feb 13. Hum Vaccin Immunother. 2014. PMID: 24525618 Free PMC article. Review.
-
Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization.Eur J Immunol. 2019 Feb;49(2):266-276. doi: 10.1002/eji.201847852. Epub 2018 Dec 21. Eur J Immunol. 2019. PMID: 30548475 Free PMC article.
References
-
- Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L, the 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med. 2009 Oct 8; - PubMed
-
- Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361 DOI: 10.1056/NEJMoa0906453. - PubMed
-
- Centers for Disease Control and Prevention Serum antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58(19):521–4. - PubMed
-
- Robbins JB, Schneerson R, Szu SC. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis. 1995 Jun;171(6):1387–98. - PubMed
-
- Epstein SL, Lo CY, Misplon JA, Bennink JR. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol. 1998 Jan 1;160(1):322–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical